TeselaGen Biotechnology Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
26
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
9
TeselaGen Biotechnology General Information
Description
Developer of a cloud-based informatics platform designed to accelerate the development of therapeutics, high-value chemicals, and agricultural products. The company's platform uses artificial intelligence for efficient rapid prototyping of recombinant molecules and synthetic evolution of machine learning engines, enabling clients to assist in the large-scale production of DNA assemblies and combinatorial libraries.
Contact Information
Website
www.teselagen.comCorporate Office
- 3130 Alpine Road
- Suite 288 Number 166
- Portola Valley, CA 94028-7549
- United States
Corporate Office
- 3130 Alpine Road
- Suite 288 Number 166
- Portola Valley, CA 94028-7549
- United States
TeselaGen Biotechnology Timeline
TeselaGen Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Accelerator/Incubator | 20-Sep-2023 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 16-Feb-2023 | Completed | Generating Revenue | |||
| 7. Seed Round | 14-Oct-2020 | Completed | Generating Revenue | |||
| 6. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 5. Seed Round | 18-Jan-2018 | Completed | Generating Revenue | |||
| 4. Grant | 07-Feb-2017 | Completed | Generating Revenue | |||
| 3. Seed Round | 07-Apr-2014 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2014 | $1.2M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | Completed | Startup |
TeselaGen Biotechnology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2 | ||||||||
| Seed 1 | ||||||||
| Seed | 2,000,000 | $0.001000 | $0.06 | $0.78 | $0.78 | 1x | $0.78 | 15.74% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
TeselaGen Biotechnology Comparisons
Industry
Financing
Details
TeselaGen Biotechnology Competitors (7)
One of TeselaGen Biotechnology’s 7 competitors is Benchling, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Benchling | Venture Capital-Backed | San Francisco, CA | ||||
| Relay Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Generate:Biomedicines | Venture Capital-Backed | Somerville, MA | ||||
| PrecisionLife | Venture Capital-Backed | Long Hanborough, United Kingdom | ||||
| AbCellera | Formerly VC-backed | Vancouver, Canada |
TeselaGen Biotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
TeselaGen Biotechnology Patents
TeselaGen Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250046396-A1 | Method, apparatus, and computer-readable medium for optimized partitioning for assembly of nucleic acid sequences | Pending | 31-Jul-2023 | ||
| US-11574703-B2 | Method, apparatus, and computer-readable medium for efficiently optimizing a phenotype with a combination of a generative and a predictive model | Active | 24-Apr-2020 | ||
| US-20210257049-A1 | Method, apparatus, and computer-readable medium for efficiently optimizing a phenotype with a combination of a generative and a predictive model | Active | 24-Apr-2020 | ||
| US-20240038329-A1 | Method, apparatus, and computer-readable medium for efficiently optimizing a phenotype with a combination of a generative and a predictive model | Active | 24-Apr-2020 | ||
| US-12217828-B2 | Method, apparatus, and computer-readable medium for efficiently optimizing a phenotype with a combination of a generative and a predictive model | Active | 24-Apr-2020 | G16B20/20 |
TeselaGen Biotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
TeselaGen Biotechnology Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Endeavor Miami | Accelerator/Incubator | |||
| WeBoost VC | Venture Capital | Minority | ||
| Propel(x) | VC-Backed Company | Minority | ||
| Taram Capital | Venture Capital | Minority | ||
| Small Business Innovation Research and Small Business Technology Transfer Programs | Government |
TeselaGen Biotechnology FAQs
-
When was TeselaGen Biotechnology founded?
TeselaGen Biotechnology was founded in 2011.
-
Where is TeselaGen Biotechnology headquartered?
TeselaGen Biotechnology is headquartered in Portola Valley, CA.
-
What is the size of TeselaGen Biotechnology?
TeselaGen Biotechnology has 26 total employees.
-
What industry is TeselaGen Biotechnology in?
TeselaGen Biotechnology’s primary industry is Biotechnology.
-
Is TeselaGen Biotechnology a private or public company?
TeselaGen Biotechnology is a Private company.
-
What is TeselaGen Biotechnology’s current revenue?
The current revenue for TeselaGen Biotechnology is .
-
How much funding has TeselaGen Biotechnology raised over time?
TeselaGen Biotechnology has raised $9.4M.
-
Who are TeselaGen Biotechnology’s investors?
Endeavor Miami, WeBoost VC, Propel(x), Taram Capital, and Small Business Innovation Research and Small Business Technology Transfer Programs are 5 of 9 investors who have invested in TeselaGen Biotechnology.
-
Who are TeselaGen Biotechnology’s competitors?
Benchling, Relay Therapeutics, Generate:Biomedicines, PrecisionLife, and AbCellera are some of the 7 competitors of TeselaGen Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
